Skip to main content
SpringerLink
Log in

Soft Tissue and Lymph Nodes of the Head and Neck

  • Chapter
  • First Online:
Book cover Practical Head and Neck Pathology

Part of the book series: Practical Anatomic Pathology ((PAP))

Abstract

A variety of reactive and neoplastic hematolymphoid disorders may be found in the head and neck. Some lymphomas have a predilection for mucosal, extranodal sites, but almost any lymphoma may present in a neck lymph node. In addition the head and neck are the primary locations for a variety of soft tissue lesions. Soft tissue lesions can be difficult to diagnose given the morphologic overlap. Knowledge of the clinical presentation and location with respect to the head and neck can help narrow the differential diagnosis. This chapter aims to discuss common soft tissue and hematopoietic tumors of the head and neck as they relate to specific sites and specific entities in the differential diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med. 2008;132(3):441–61.

    PubMed  Google Scholar 

  2. Slack GW. The pathology of reactive lymphadenopathies: a discussion of common reactive patterns and their malignant mimics. Arch Pathol Lab Med. 2016;140(9):881–92.

    Article  CAS  PubMed  Google Scholar 

  3. Tzankov A, Dirnhofer S. A pattern-based approach to reactive lymphadenopathies. Semin Diagn Pathol. 2018;35(1):4–19.

    Article  PubMed  Google Scholar 

  4. Childs CC, Parham DM, Berard CW. Infectious mononucleosis. The spectrum of morphologic changes simulating lymphoma in lymph nodes and tonsils. Am J Surg Pathol. 1987;11(2):122–32.

    Article  CAS  PubMed  Google Scholar 

  5. Strickler JG, Fedeli F, Horwitz CA, Copenhaver CM, Frizzera G. Infectious mononucleosis in lymphoid tissue. Histopathology, in situ hybridization, and differential diagnosis. Arch Pathol Lab Med. 1993;117(3):269–78.

    CAS  PubMed  Google Scholar 

  6. Thakral B, Zhou J, Medeiros LJ. Extranodal hematopoietic neoplasms and mimics in the head and neck: an update. Hum Pathol. 2015;46(8):1079–100.

    Article  PubMed  Google Scholar 

  7. Louissaint A Jr, Ferry JA, Soupir CP, Hasserjian RP, Harris NL, Zukerberg LR. Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features. Mod Pathol. 2012;25(8):1149–59.

    Article  CAS  PubMed  Google Scholar 

  8. Cheuk W, Chan AK, Wong MC, Chan JK. Confirmation of diagnosis of cat scratch disease by immunohistochemistry. Am J Surg Pathol. 2006;30(2):274–5.

    Article  CAS  PubMed  Google Scholar 

  9. Hansmann Y, DeMartino S, Piemont Y, Meyer N, Mariet P, Heller R, et al. Diagnosis of cat scratch disease with detection of Bartonella henselae by PCR: a study of patients with lymph node enlargement. J Clin Microbiol. 2005;43(8):3800–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Asano S. Granulomatous lymphadenitis. J Clin Exp Hematop. 2012;52(1):1–16.

    Article  PubMed  Google Scholar 

  11. Caponetti GC, Pantanowitz L, Marconi S, Havens JM, Lamps LW, Otis CN. Evaluation of immunohistochemistry in identifying Bartonella henselae in cat-scratch disease. Am J Clin Pathol. 2009;131(2):250–6.

    Article  CAS  PubMed  Google Scholar 

  12. Lamps LW, Scott MA. Cat-scratch disease: historic, clinical, and pathologic perspectives. Am J Clin Pathol. 2004;121(Suppl):S71–80.

    PubMed  Google Scholar 

  13. Penn EB Jr, Goudy SL. Pediatric inflammatory adenopathy. Otolaryngol Clin N Am. 2015;48(1):137–51.

    Article  Google Scholar 

  14. Eapen M, Mathew CF, Aravindan KP. Evidence based criteria for the histopathological diagnosis of toxoplasmic lymphadenopathy. J Clin Pathol. 2005;58(11):1143–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kojima M, Kashimura M, Itoh H, Noro M, Matsuda H, Tsukamoto N, et al. Infectious mononucleosis lymphoadenitis showing histologic findings indistinguishable from toxoplasma lymphadenitis. A report of three cases. Pathol Res Pract. 2010;206(6):361–4.

    Article  PubMed  Google Scholar 

  16. Saxena S, Kumar S, Kharbanda J. Toxoplasmosis submandibular lymphadenitis: report of an unusual case with a brief review. J Oral Maxillofac Pathol. 2018;22(1):116–20.

    PubMed  PubMed Central  Google Scholar 

  17. Rosenberg TL, Nolder AR. Pediatric cervical lymphadenopathy. Otolaryngol Clin N Am. 2014;47(5):721–31.

    Article  Google Scholar 

  18. Shimizu Y, Hidaka H, Ozawa D, Kakuta R, Nomura K, Yano H, et al. Clinical and bacteriological differences of deep neck infection in pediatric and adult patients: review of 123 cases. Int J Pediatr Otorhinolaryngol. 2017;99:95–9.

    Article  PubMed  Google Scholar 

  19. Rives P, Joubert M, Launay E, Guillouzouic A, Espitalier F, Malard O. Cervicofacial non-tuberculous mycobacteria: a report of 30 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133(2):107–11.

    Article  CAS  PubMed  Google Scholar 

  20. Gould E, Porto R, Albores-Saavedra J, Ibe MJ. Dermatopathic lymphadenitis. The spectrum and significance of its morphologic features. Arch Pathol Lab Med. 1988;112(11):1145–50.

    CAS  PubMed  Google Scholar 

  21. Medeiros LJ, Kaynor B, Harris NL. Lupus lymphadenitis: report of a case with immunohistologic studies on frozen sections. Hum Pathol. 1989;20(3):295–9.

    Article  CAS  PubMed  Google Scholar 

  22. Kojima M, Motoori T, Asano S, Nakamura S. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract. 2007;203(6):423–31.

    Article  PubMed  Google Scholar 

  23. Gru AA, O’Malley DP. Autoimmune and medication-induced lymphadenopathies. Semin Diagn Pathol. 2018;35(1):34–43.

    Article  PubMed  Google Scholar 

  24. Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, et al. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013;91(1):20–8.

    Article  CAS  PubMed  Google Scholar 

  25. Kojima M, Nakamura S, Morishita Y, Itoh H, Yoshida K, Ohno Y, et al. Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathol Int. 2000;50(4):304–12.

    Article  CAS  PubMed  Google Scholar 

  26. Jeon YK, Paik JH, Park S-S, Park SO, Kim YA, Kim JE, et al. Spectrum of lymph node pathology in adult onset Still’s disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol. 2004;57(10):1052–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Abbondanzo SL, Irey NS, Frizzera G. Dilantin-associated lymphadenopathy. Spectrum of histopathologic patterns. Am J Surg Pathol. 1995;19(6):675–86.

    Article  Google Scholar 

  28. Katzin WE, Julius CJ, Tubbs RR, McHenry MC. Lymphoproliferative disorders associated with carbamazepine. Arch Pathol Lab Med. 1990;114(12):1244–8.

    CAS  PubMed  Google Scholar 

  29. Choi TS, Doh KS, Kim SH, Jang MS, Suh KS, Kim ST. Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome. Br J Dermatol. 2003;148(4):730–6.

    Article  CAS  PubMed  Google Scholar 

  30. Sato R, Itoh M, Suzuki H, Kusuhara Y, Nakayama M, Kikuchi S, et al. Pathological findings of lymphadenopathy in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic syndrome (DRESS): similarities with angioimmunoblastic T-cell lymphoma. Eur J Dermatol. 2017;27(2):201–2.

    PubMed  Google Scholar 

  31. Dumas G, Prendki V, Haroche J, Amoura Z, Cacoub P, Galicier L, et al. Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature. Medicine (Baltimore). 2014;93(24):372–82.

    Article  Google Scholar 

  32. Pepe F, Disma S, Teodoro C, Pepe P, Magro G. Kikuchi-Fujimoto disease: a clinicopathologic update. Pathologica. 2016;108(3):120–9.

    CAS  PubMed  Google Scholar 

  33. Hutchinson CB, Wang E. Kikuchi-Fujimoto disease. Arch Pathol Lab Med. 2010;134(2):289–93.

    PubMed  Google Scholar 

  34. Lamzaf L, Harmouche H, Maamar M, Adnaoui M, Aouni M, Tazi MZ. Kikuchi-Fujimoto disease: report of 4 cases and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131(6):329–32.

    Article  CAS  PubMed  Google Scholar 

  35. O'Malley DP, Grimm KE. Reactive lymphadenopathies that mimic lymphoma: entities of unknown etiology. Semin Diagn Pathol. 2013;30(2):137–45.

    Article  PubMed  Google Scholar 

  36. Hu S, Kuo TT, Hong HS. Lupus lymphadenitis simulating Kikuchi's lymphadenitis in patients with systemic lupus erythematosus: a clinicopathological analysis of six cases and review of the literature. Pathol Int. 2003;53(4):221–6.

    Article  PubMed  Google Scholar 

  37. Chen H, Thompson LD, Aguilera NS, Abbondanzo SL. Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2004;28(4):505–13.

    Article  PubMed  Google Scholar 

  38. Mrowka-Kata K, Kata D, Kyrcz-Krzemien S, Helbig G. Kikuchi-Fujimoto and Kimura diseases: the selected, rare causes of neck lymphadenopathy. Eur Arch Otorhinolaryngol. 2010;267(1):5–11.

    Article  PubMed  Google Scholar 

  39. Abuel-Haija M, Hurford MT. Kimura disease. Arch Pathol Lab Med. 2007;131(4):650–1.

    PubMed  Google Scholar 

  40. Sun QF, Xu DZ, Pan SH, Ding JG, Xue ZQ, Miao CS, et al. Kimura disease: review of the literature. Intern Med J. 2008;38(8):668–72.

    Article  CAS  PubMed  Google Scholar 

  41. Bedran NR, Carlos R, de Andrade BAB, Bueno APS, Romanach MJ, Milito CB. Clinicopathological and immunohistochemical study of head and neck Langerhans cell histiocytosis from Latin America. Head Neck Pathol. 2018;12(4):431–39.

    Google Scholar 

  42. Lewoczko KB, Rohman GT, LeSueur JR, Stocks RM, Thompson JW. Head and neck manifestations of Langerhan’s cell histiocytosis in children: a 46-year experience. Int J Pediatr Otorhinolaryngol. 2014;78(11):1874–6.

    Article  CAS  PubMed  Google Scholar 

  43. Cracolici V, Gurbuxani S, Ginat DT. Head and neck sinus histiocytosis with massive lymphadenopathy radiology-pathology correlation. Head Neck Pathol. 2018. [Epub ahead of print].

    Google Scholar 

  44. Urabe A, Tsuneyoshi M, Enjoji M. Epithelioid hemangioma versus Kimura’s disease. A comparative clinicopathologic study. Am J Surg Pathol. 1987;11(10):758–66.

    Article  CAS  PubMed  Google Scholar 

  45. Menke DM, Camoriano JK, Banks PM. Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol. 1992;5(5):525–30.

    CAS  PubMed  Google Scholar 

  46. Ruco LP, Gearing AJ, Pigott R, Pomponi D, Burgio VL, Cafolla A, et al. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman’s disease): evidence for dysplasia of follicular dendritic reticulum cells. Histopathology. 1991;19(6):523–8.

    Article  CAS  PubMed  Google Scholar 

  47. Danon AD, Krishnan J, Frizzera G. Morpho-immunophenotypic diversity of Castleman’s disease, hyaline-vascular type: with emphasis on a stroma-rich variant and a new pathogenetic hypothesis. Virchows Arch A Pathol Anat Histopathol. 1993;423(5):369–82.

    Article  CAS  PubMed  Google Scholar 

  48. Muzes G, Sipos F, Csomor J, Sreter L. Multicentric Castleman’s disease: a challenging diagnosis. Pathol Oncol Res. 2013;19(3):345–51.

    Article  CAS  PubMed  Google Scholar 

  49. Amin HM, Medeiros LJ, Manning JT, Jones D. Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman’s disease. Am J Surg Pathol. 2003;27(1):91–100.

    Article  PubMed  Google Scholar 

  50. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95(4):1406–12.

    Article  CAS  PubMed  Google Scholar 

  51. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A. 1999;96(8):4546–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Liu M, Liu B, Liu B, Cui X, Yang S, Wang Q, et al. Mucosa-associated lymphoid tissue lymphoma of the larynx: a case report and literature review. Medicine (Baltimore). 2015;94(17):e788.

    Article  Google Scholar 

  53. Cavalot AL, Preti G, Vione N, Nazionale G, Palonta F, Fadda GL. Isolated primary non-Hodgkin’s malignant lymphoma of the larynx. J Laryngol Otol. 2001;115(4):324–6.

    Article  CAS  PubMed  Google Scholar 

  54. Picard A, Cardinne C, Denoux Y, Wagner I, Chabolle F, Bach CA. Extranodal lymphoma of the head and neck: a 67-case series. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132(2):71–5.

    Article  CAS  PubMed  Google Scholar 

  55. Iyengar P, Mazloom A, Shihadeh F, Berjawi G, Dabaja B. Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes. Cancer. 2010;116(16):3825–9.

    Article  PubMed  Google Scholar 

  56. Urquhart A, Berg R. Hodgkin’s and non-Hodgkin’s lymphoma of the head and neck. Laryngoscope. 2001;111(9):1565–9.

    Article  CAS  PubMed  Google Scholar 

  57. Weber AL, Rahemtullah A, Ferry JA. Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am. 2003;13(3):371–92.

    Article  PubMed  Google Scholar 

  58. Zapater E, Bagan JV, Carbonell F, Basterra J. Malignant lymphoma of the head and neck. Oral Dis. 2010;16(2):119–28.

    Article  CAS  PubMed  Google Scholar 

  59. Mian M, Capello D, Ventre MB, Grazio D, Svaldi M, Rossi A, et al. Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study). Ann Hematol. 2014;93(2):221–31.

    Article  CAS  PubMed  Google Scholar 

  60. Takano S, Matsushita N, Oishi M, Okamoto S, Teranishi Y, Yokota C, et al. Site-specific analysis of B-cell non-Hodgkin’s lymphomas of the head and neck: a retrospective 10-year observation. Acta Otolaryngol. 2015;135(11):1168–71.

    Article  CAS  PubMed  Google Scholar 

  61. Brown NA, Elenitoba-Johnson KS. Update from the 4th edition of the World Health Organization classification of head and neck tumours: hematolymphoid tumours. Head Neck Pathol. 2017;11(1):96–109.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th, revised ed. Lyon: International Agency for Research on Cancer; 2017. p. 585.

    Google Scholar 

  63. Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM, Maestre L, Sanchez-Verde L, Roncador G, et al. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica. 2010;95(8):1342–9.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Montes-Moreno S, Montalban C, Piris MA. Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge. Leuk Lymphoma. 2012;53(2):185–94.

    Article  CAS  PubMed  Google Scholar 

  65. Gerry D, Lentsch EJ. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck. Otolaryngol Head Neck Surg. 2013;148(6):974–81.

    Article  PubMed  Google Scholar 

  66. Straetmans J, Stokroos R. Extramedullary plasmacytomas in the head and neck region. Eur Arch Otorhinolaryngol. 2008;265(11):1417–23.

    Article  PubMed  Google Scholar 

  67. Sciallis AP, Law ME, Inwards DJ, McClure RF, Macon WR, Kurtin PJ, et al. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol. 2012;25(7):983–92.

    Article  CAS  PubMed  Google Scholar 

  68. Wang W, Cai Y, Sheng W, Lu H, Li X. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(1):96–104.

    Article  PubMed  Google Scholar 

  69. Vazquez A, Khan MN, Sanghvi S, Patel NR, Caputo JL, Baredes S, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the salivary glands: a population-based study from 1994 to 2009. Head Neck. 2015;37(1):18–22.

    Article  PubMed  Google Scholar 

  70. Vega F, Lin P, Medeiros LJ. Extranodal lymphomas of the head and neck. Ann Diagn Pathol. 2005;9(6):340–50.

    Article  PubMed  Google Scholar 

  71. Pang J, Mydlarz WK, Gooi Z, Waters KM, Bishop J, Sciubba JJ, et al. Follicular dendritic cell sarcoma of the head and neck: case report, literature review, and pooled analysis of 97 cases. Head Neck. 2016;38(Suppl 1):E2241–9.

    Article  PubMed  Google Scholar 

  72. Wu A, Pullarkat S. Follicular dendritic cell sarcoma. Arch Pathol Lab Med. 2016;140(2):186–90.

    Article  CAS  PubMed  Google Scholar 

  73. Zhou J, Wang G, Zhang D, Yin Y, Pang X, Zhang J, et al. Primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck rarely involving epiglottis: clinicopathological, immunohistomchemical and genetic features of a case. Int J Clin Exp Pathol. 2015;8(9):11685–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  74. King RL, Howard MT, Bagg A. Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors. Adv Anat Pathol. 2014;21(1):12–25.

    Article  CAS  PubMed  Google Scholar 

  75. Mathas S, Hartmann S, Kuppers R. Hodgkin lymphoma: pathology and biology. Semin Hematol. 2016;53(3):139–47.

    Article  PubMed  Google Scholar 

  76. Karube K, Niino D, Kimura Y, Ohshima K. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma. Pathol Res Pract. 2013;209(4):201–7.

    Article  PubMed  Google Scholar 

  77. Ansell SM. Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management. Am J Hematol. 2012;87(12):1096–103.

    Article  PubMed  Google Scholar 

  78. Kuppers R, Engert A, Hansmann ML. Hodgkin lymphoma. J Clin Invest. 2012;122(10):3439–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Slack GW, Ferry JA, Hasserjian RP, Sohani AR, Longtine JA, Harris NL, et al. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis. Leuk Lymphoma. 2009;50(6):937–43.

    Article  CAS  PubMed  Google Scholar 

  80. Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003;27(10):1346–56.

    Article  PubMed  Google Scholar 

  81. Hartmann S, Eichenauer DA, Plutschow A, Mottok A, Bob R, Koch K, et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood. 2013;122(26):4246–52; quiz 92.

    Article  CAS  PubMed  Google Scholar 

  82. Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Dominguez-Franjo P, et al. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol. 2008;32(8):1252–7.

    Article  PubMed  Google Scholar 

  83. Savage KJ, Mottok A, Fanale M. Nodular lymphocyte-predominant Hodgkin lymphoma. Semin Hematol. 2016;53(3):190–202.

    Article  PubMed  Google Scholar 

  84. Burns BF, Colby TV, Dorfman RF. Differential diagnostic features of nodular L & H Hodgkin’s disease, including progressive transformation of germinal centers. Am J Surg Pathol. 1984;8(4):253–61.

    Article  CAS  PubMed  Google Scholar 

  85. Hansmann ML, Fellbaum C, Hui PK, Moubayed P. Progressive transformation of germinal centers with and without association to Hodgkin’s disease. Am J Clin Pathol. 1990;93(2):219–26.

    Article  CAS  PubMed  Google Scholar 

  86. Osborne BM, Butler JJ. Clinical implications of progressive transformation of germinal centers. Am J Surg Pathol. 1984;8(10):725–33.

    Article  CAS  PubMed  Google Scholar 

  87. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17(12):3835–49.

    Article  CAS  PubMed  Google Scholar 

  88. Jiang M, Bennani NN, Feldman AL. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms. Expert Rev Hematol. 2017;10(3):239–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Bea S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernandez L, et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood. 1999;93(12):4365–74.

    CAS  PubMed  Google Scholar 

  90. Determann O, Hoster E, Ott G, Wolfram Bernd H, Loddenkemper C, Leo Hansmann M, et al. Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL network and the German Low Grade Lymphoma Study Group. Blood. 2008;111(4):2385–7.

    Article  CAS  PubMed  Google Scholar 

  91. Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70(4):1408–18.

    Article  CAS  PubMed  Google Scholar 

  92. Geisler CH, Kolstad A, Laurell A, Raty R, Jerkeman M, Eriksson M, et al. The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood. 2010;115(8):1530–3.

    Article  CAS  PubMed  Google Scholar 

  93. Greiner TC, Moynihan MJ, Chan WC, Lytle DM, Pedersen A, Anderson JR, et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood. 1996;87(10):4302–10.

    Article  CAS  PubMed  Google Scholar 

  94. Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008;111(2):558–65.

    Article  CAS  PubMed  Google Scholar 

  95. Nordstrom L, Sernbo S, Eden P, Gronbaek K, Kolstad A, Raty R, et al. SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study. Br J Haematol. 2014;166(1):98–108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Abdel-Ghafar AA, El Din El Telbany MA, Mahmoud HM, El-Sakhawy YN. Immunophenotyping of chronic B-cell neoplasms: flow cytometry versus immunohistochemistry. Hematol Rep. 2012;4(1):e3.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Hsi ED, Yegappan S. Lymphoma immunophenotyping: a new era in paraffin-section immunohistochemistry. Adv Anat Pathol. 2001;8(4):218–39.

    Article  CAS  PubMed  Google Scholar 

  98. Linch DC. Burkitt lymphoma in adults. Br J Haematol. 2012;156(6):693–703.

    Article  CAS  PubMed  Google Scholar 

  99. Sohani AR, Hasserjian RP. Diagnosis of Burkitt lymphoma and related high-grade B-cell neoplasms. Surg Pathol Clin. 2010;3(4):1035–59.

    Article  PubMed  Google Scholar 

  100. Haralambieva E, Boerma EJ, van Imhoff GW, Rosati S, Schuuring E, Muller-Hermelink HK, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol. 2005;29(8):1086–94.

    PubMed  Google Scholar 

  101. Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009;114(11):2273–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Jiang M, Bennani NN, Feldman AL. Lymphoma classification update: B-cell non-Hodgkin lymphomas. Expert Rev Hematol. 2017;10(5):405–15.

    Article  CAS  PubMed  Google Scholar 

  103. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503–11.

    Article  CAS  PubMed  Google Scholar 

  104. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–82.

    Article  CAS  PubMed  Google Scholar 

  105. Hu S, Xu-Monette ZY, Tzankov A, Green T, Wu L, Balasubramanyam A, et al. MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood. 2013;121(20):4021–31; quiz 250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Lee DY, Kang K, Jung H, Park YM, Cho JG, Baek SK, et al. Extranodal involvement of diffuse large B-cell lymphoma in the head and neck: an indicator of good prognosis. Auris Nasus Larynx. 2018.

    Google Scholar 

  107. Li JM, Hou J, Li L, Wang Y. Immunohistochemical subtypes of diffuse large B-cell lymphoma in the head and neck region. Genet Mol Res. 2015;14(2):3889–96.

    Article  CAS  PubMed  Google Scholar 

  108. Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, et al. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood. 2014;124(15):2354–61.

    Article  CAS  PubMed  Google Scholar 

  109. Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol. 2010;34(3):327–40.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Swerdlow SH. Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC. Hematology Am Soc Hematol Educ Program. 2014;2014(1):90–9.

    Article  PubMed  Google Scholar 

  111. Falini B, Lenze D, Hasserjian R, Coupland S, Jaehne D, Soupir C, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia. 2007;21(7):1566–70.

    Article  CAS  PubMed  Google Scholar 

  112. Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21(2):340–50.

    Article  CAS  PubMed  Google Scholar 

  113. Zhou J, Bell D, Medeiros LJ. Myeloid sarcoma of the head and neck region. Arch Pathol Lab Med. 2013;137(11):1560–8.

    Article  PubMed  Google Scholar 

  114. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH Jr, McClain K, et al. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg. 1983;198(3):356–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Lones MA, Mishalani S, Shintaku IP, Weiss LM, Nichols WS, Said JW. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer’s ring. Hum Pathol. 1995;26(5):525–30.

    Article  CAS  PubMed  Google Scholar 

  116. Campisi P, Allen UD, Ngan BY, Hawkes M, Forte V. Utility of head and neck biopsies in the evaluation of posttransplant lymphoproliferative disorder. Otolaryngol Head Neck Surg. 2007;137(2):296–300.

    Article  PubMed  Google Scholar 

  117. Heyes R, Northfelt DW, Lott DG. Posttransplant lymphoproliferative disorder: otolaryngological manifestations and management. Otolaryngol Head Neck Surg. 2017;157(5):750–9.

    Article  PubMed  Google Scholar 

  118. Ojha J, Islam N, Cohen DM, Marshal D, Reavis MR, Bhattacharyya I. Post-transplant lymphoproliferative disorders of oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(5):589–96.

    Article  PubMed  Google Scholar 

  119. Akbas A, Tiede C, Lemound J, Maecker-Kolhoff B, Kreipe H, Hussein K. Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation. Transpl Int. 2015;28(11):1299–307.

    Article  PubMed  Google Scholar 

  120. Adams A, Mankad K, Offiah C, Childs L. Branchial cleft anomalies: a pictorial review of embryological development and spectrum of imaging findings. Insights Imag. 2016;7(1):69–76.

    Article  Google Scholar 

  121. Mandell DL. Head and neck anomalies related to the branchial apparatus. Otolaryngol Clin N Am. 2000;33(6):1309–32.

    Article  CAS  Google Scholar 

  122. Waldhausen JH. Branchial cleft and arch anomalies in children. Semin Pediatr Surg. 2006;15(2):64–9.

    Article  PubMed  Google Scholar 

  123. Liberman M, Kay S, Emil S, Flageole H, Nguyen LT, Tewfik TL, et al. Ten years of experience with third and fourth branchial remnants. J Pediatr Surg. 2002;37(5):685–90.

    Article  PubMed  Google Scholar 

  124. Chavan S, Deshmukh R, Karande P, Ingale Y. Branchial cleft cyst: a case report and review of literature. J Oral Maxillofac Pathol. 2014;18(1):150.

    PubMed  PubMed Central  Google Scholar 

  125. de Tristan J, Zenk J, Künzel J, Psychogios G, Iro H. Thyroglossal duct cysts: 20 years’ experience (1992–2011). Eur Arch Otorhinolaryngol. 2015;272(9):2513–9.

    Article  PubMed  Google Scholar 

  126. Dedivitis RA, Camargo DL, Peixoto GL, Weissman L, Guimarães AV. Thyroglossal duct: a review of 55 cases. J Am Coll Surg. 2002;194(3):274–7.

    Article  PubMed  Google Scholar 

  127. Josephson GD, Spencer WR, Josephson JS. Thyroglossal duct cyst: the New York eye and ear infirmary experience and a literature review. Ear Nose Throat J. 1998;77(8):642–4, 6–7, 51.

    Article  CAS  PubMed  Google Scholar 

  128. Lin ST, Tseng FY, Hsu CJ, Yeh TH, Chen YS. Thyroglossal duct cyst: a comparison between children and adults. Am J Otolaryngol. 2008;29(2):83–7.

    Article  PubMed  Google Scholar 

  129. McGurk M. Management of the ranula. J Oral Maxillofac Surg. 2007;65(1):115–6.

    Article  PubMed  Google Scholar 

  130. Work WP. Cysts and congenital lesions of the parotid gland. Otolaryngol Clin N Am. 1977;10(2):339–43.

    CAS  Google Scholar 

  131. Thompson LD, Herrera HB, Lau SK. A clinicopathologic series of 685 thyroglossal duct remnant cysts. Head Neck Pathol. 2016;10(4):465–74.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Zhao YF, Jia Y, Chen XM, Zhang WF. Clinical review of 580 ranulas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(3):281–7.

    Article  PubMed  Google Scholar 

  133. Katabi N, Lewis JS. Update from the 4th edition of the World Health Organization classification of head and neck tumours: what is new in the 2017 WHO blue book for tumors and tumor-like lesions of the neck and lymph nodes. Head Neck Pathol. 2017;11(1):48–54.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Paradis J, Koltai PJ. Pediatric teratoma and dermoid cysts. Otolaryngol Clin N Am. 2015;48(1):121–36.

    Article  Google Scholar 

  135. Mattingly JK, Arganbright JM, Lovell MA, Chan KH. Cervical bronchogenic cysts: case report and review of the literature. Am J Otolaryngol. 2014;35(5):655–7.

    Article  PubMed  Google Scholar 

  136. Woolgar JA. Histological distribution of cervical lymph node metastases from intraoral/oropharyngeal squamous cell carcinomas. Br J Oral Maxillofac Surg. 1999;37(3):175–80.

    Article  CAS  PubMed  Google Scholar 

  137. Mukherji SK, Armao D, Joshi VM. Cervical nodal metastases in squamous cell carcinoma of the head and neck: what to expect. Head Neck. 2001;23(11):995–1005.

    Article  CAS  PubMed  Google Scholar 

  138. April MM, Ward RF, Garelick JM. Diagnosis, management, and follow-up of congenital head and neck teratomas. Laryngoscope. 1998;108(9):1398–401.

    Article  CAS  PubMed  Google Scholar 

  139. Gluckman JL, Robbins KT, Fried MP. Cervical metastatic squamous carcinoma of unknown or occult primary source. Head Neck. 1990;12(5):440–3.

    Article  CAS  PubMed  Google Scholar 

  140. Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg. 2005;32(1):99–116, ix.

    Article  PubMed  Google Scholar 

  141. Coleman SC, Smith JC, Burkey BB, Day TA, Page RN, Netterville JL. Long-standing lateral neck mass as the initial manifestation of well-differentiated thyroid carcinoma. Laryngoscope. 2000;110(2 Pt 1):204–9.

    Article  CAS  PubMed  Google Scholar 

  142. Castelijns PS, Woensdregt K, Hoevenaars B, Nieuwenhuijzen GA. Intra-abdominal esophageal duplication cyst: a case report and review of the literature. World J Gastrointest Surg. 2014;6(6):112–6.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Watanobe I, Ito Y, Akimoto E, Sekine Y, Haruyama Y, Amemiya K, et al. Laparoscopic resection of an intra-abdominal esophageal duplication cyst: a case report and literature review. Case Rep Surg. 2015;2015:940768.

    PubMed  PubMed Central  Google Scholar 

  144. Al-Brahim N, Asa SL. Papillary thyroid carcinoma: an overview. Arch Pathol Lab Med. 2006;130(7):1057–62.

    PubMed  Google Scholar 

  145. Khanafshar E, Lloyd RV. The spectrum of papillary thyroid carcinoma variants. Adv Anat Pathol. 2011;18(1):90–7.

    Article  PubMed  Google Scholar 

  146. Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg. 1999;120(6):834–40.

    Article  CAS  PubMed  Google Scholar 

  147. Peng KA, Grogan T, Wang MB. Head and neck sarcomas: analysis of the SEER database. Otolaryngol Head Neck Surg. 2014;151(4):627–33.

    Article  PubMed  PubMed Central  Google Scholar 

  148. Purgina B, Lai CK. Distinctive head and neck bone and soft tissue neoplasms. Surg Pathol Clin. 2017;10(1):223–79.

    Article  PubMed  Google Scholar 

  149. Vassiliou LV, Lalabekyan B, Jay A, Liew C, Whelan J, Newman L, et al. Head and neck sarcomas: a single institute series. Oral Oncol. 2017;65:16–22.

    Article  PubMed  Google Scholar 

  150. Fletcher CD. Distinctive soft tissue tumors of the head and neck. Mod Pathol. 2002;15(3):324–30.

    Article  PubMed  Google Scholar 

  151. Butler RT, Patel RM, McHugh JB. Head and neck schwannomas: 20-year experience of a single institution excluding cutaneous and acoustic sites. Head Neck Pathol. 2016;10(3):286–91.

    Article  PubMed  PubMed Central  Google Scholar 

  152. Hornick JL, Fletcher CD. Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol. 2005;29(7):845–58.

    Article  PubMed  Google Scholar 

  153. Marocchio LS, Oliveira DT, Pereira MC, Soares CT, Fleury RN. Sporadic and multiple neurofibromas in the head and neck region: a retrospective study of 33 years. Clin Oral Investig. 2007;11(2):165–9.

    Article  PubMed  Google Scholar 

  154. Leu YS, Chang KC. Extracranial head and neck schwannomas: a review of 8 years experience. Acta Otolaryngol. 2002;122(4):435–7.

    Article  CAS  PubMed  Google Scholar 

  155. Owosho AA, Estilo CL, Huryn JM, Chi P, Antonescu CR. A clinicopathologic study of head and neck malignant peripheral nerve sheath tumors. Head Neck Pathol. 2018;12(2):151–9.

    Article  PubMed  Google Scholar 

  156. Le Guellec S, Macagno N, Velasco V, Lamant L, Lae M, Filleron T, et al. Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions. Mod Pathol. 2017;30(12):1677–87.

    Article  CAS  PubMed  Google Scholar 

  157. Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol. 2012;123(3):295–319.

    Article  PubMed  PubMed Central  Google Scholar 

  158. Azani AB, Bishop JA, Thompson LD. Sinonasal tract neurofibroma: a clinicopathologic series of 12 cases with a review of the literature. Head Neck Pathol. 2015;9(3):323–33.

    Article  PubMed  Google Scholar 

  159. Fletcher CD, Davies SE, McKee PH. Cellular schwannoma: a distinct pseudosarcomatous entity. Histopathology. 1987;11(1):21–35.

    Article  CAS  PubMed  Google Scholar 

  160. Fletcher CD. Recently characterized soft tissue tumors that bring biologic insight. Mod Pathol. 2014;27(Suppl 1):S98–112.

    Article  PubMed  Google Scholar 

  161. Stasik CJ, Tawfik O. Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor). Arch Pathol Lab Med. 2006;130(12):1878–81.

    PubMed  Google Scholar 

  162. Turner JH, Richmon JD. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg. 2011;145(6):967–73.

    Article  PubMed  Google Scholar 

  163. de Trey LA, Schmid S, Huber GF. Multifocal adult rhabdomyoma of the head and neck manifestation in 7 locations and review of the literature. Case Rep Otolaryngol. 2013;2013:758416.

    PubMed  PubMed Central  Google Scholar 

  164. Papaspyrou G, Werner JA, Roessler M, Devaney KO, Rinaldo A, Ferlito A. Adult rhabdomyoma in the parapharyngeal space: report of 2 cases and review of the literature. Am J Otolaryngol. 2011;32(3):240–6.

    Article  PubMed  Google Scholar 

  165. Eppsteiner RW, DeYoung BR, Milhem MM, Pagedar NA. Leiomyosarcoma of the head and neck: a population-based analysis. Arch Otolaryngol Head Neck Surg. 2011;137(9):921–4.

    Article  PubMed  PubMed Central  Google Scholar 

  166. Suster S. Epithelioid leiomyosarcoma of the skin and subcutaneous tissue. Clinicopathologic, immunohistochemical, and ultrastructural study of five cases. Am J Surg Pathol. 1994;18(3):232–40.

    Article  CAS  PubMed  Google Scholar 

  167. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol. 2001;14(6):595–603.

    Article  CAS  PubMed  Google Scholar 

  168. Mentzel T, Kuhnen C. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases. Virchows Arch. 2006;449(5):554–60.

    Article  PubMed  Google Scholar 

  169. Nascimento AF, Fletcher CD. Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol. 2005;29(8):1106–13.

    PubMed  Google Scholar 

  170. Szuhai K, de Jong D, Leung WY, Fletcher CD, Hogendoorn PC. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. J Pathol. 2014;232(3):300–7.

    Article  CAS  PubMed  Google Scholar 

  171. Miettinen M. Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis. Mod Pathol. 2014;27(Suppl 1):S17–29.

    Article  PubMed  PubMed Central  Google Scholar 

  172. Schütz A, Smeets R, Driemel O, Hakim SG, Kosmehl H, Hanken H, et al. Primary and secondary leiomyosarcoma of the oral and perioral region – clinicopathological and immunohistochemical analysis of a rare entity with a review of the literature. J Oral Maxillofac Surg. 2013;71(6):1132–42.

    Article  PubMed  Google Scholar 

  173. Yoshida A, Shibata T, Wakai S, Ushiku T, Tsuta K, Fukayama M, et al. Anaplastic lymphoma kinase status in rhabdomyosarcomas. Mod Pathol. 2013;26(6):772–81.

    Article  CAS  PubMed  Google Scholar 

  174. Yasuda T, Perry KD, Nelson M, Bui MM, Nasir A, Goldschmidt R, et al. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Hum Pathol. 2009;40(3):341–8.

    Article  CAS  PubMed  Google Scholar 

  175. Davicioni E, Anderson MJ, Finckenstein FG, Lynch JC, Qualman SJ, Shimada H, et al. Molecular classification of rhabdomyosarcoma – genotypic and phenotypic determinants of diagnosis: a report from the Children’s Oncology Group. Am J Pathol. 2009;174(2):550–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  176. Parham DM, Barr FG. Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol. 2013;20(6):387–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  177. Mallen-St Clair J, Arshi A, Abemayor E, St John M. Factors associated with survival in patients with synovial cell sarcoma of the head and neck: an analysis of 167 cases using the SEER (surveillance, epidemiology, and end results) database. JAMA Otolaryngol Head Neck Surg. 2016;142(6):576–83.

    Article  PubMed  Google Scholar 

  178. Salcedo-Hernandez RA, Lino-Silva LS, Luna-Ortiz K. Synovial sarcomas of the head and neck: comparative analysis with synovial sarcoma of the extremities. Auris Nasus Larynx. 2013;40(5):476–80.

    Article  PubMed  Google Scholar 

  179. Wang H, Zhang J, He X, Niu Y. Synovial sarcoma in the oral and maxillofacial region: report of 4 cases and review of the literature. J Oral Maxillofac Surg. 2008;66(1):161–7.

    Article  PubMed  Google Scholar 

  180. Thway K, Fisher C. Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol. 2014;18(6):369–80.

    Article  PubMed  Google Scholar 

  181. Bahrami A, Folpe AL. Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol. 2010;34(10):1504–13.

    Article  PubMed  Google Scholar 

  182. Borucki RB, Neskey DM, Lentsch EJ. Malignant fibrous histiocytoma: database review suggests a favorable prognosis in the head and neck. Laryngoscope. 2018;128(4):885–8.

    Article  PubMed  Google Scholar 

  183. Goldblum JR. An approach to pleomorphic sarcomas: can we subclassify, and does it matter? Mod Pathol. 2014;27(Suppl 1):S39–46.

    Article  PubMed  Google Scholar 

  184. Gujrathi CS, Donald PJ. Current trends in the diagnosis and management of head and neck paragangliomas. Curr Opin Otolaryngol Head Neck Surg. 2005;13(6):339–42.

    Article  PubMed  Google Scholar 

  185. Bacchi CE, Silva TR, Zambrano E, Plaza J, Suster S, Luzar B, et al. Epithelioid angiosarcoma of the skin: a study of 18 cases with emphasis on its clinicopathologic spectrum and unusual morphologic features. Am J Surg Pathol. 2010;34(9):1334–43.

    Article  PubMed  Google Scholar 

  186. Bandhlish A, Leon Barnes E, Rabban JT, McHugh JB. Perivascular epithelioid cell tumors (PEComas) of the head and neck: report of three cases and review of the literature. Head Neck Pathol. 2011;5(3):233–40.

    Article  PubMed  PubMed Central  Google Scholar 

  187. Chamberlain BK, McClain CM, Gonzalez RS, Coffin CM, Cates JM. Alveolar soft part sarcoma and granular cell tumor: an immunohistochemical comparison study. Hum Pathol. 2014;45(5):1039–44.

    Article  CAS  PubMed  Google Scholar 

  188. Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG. Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation. Am J Surg Pathol. 1998;22(7):779–94.

    Article  CAS  PubMed  Google Scholar 

  189. Heerema MG, Suurmeijer AJ. Sox10 immunohistochemistry allows the pathologist to differentiate between prototypical granular cell tumors and other granular cell lesions. Histopathology. 2012;61(5):997–9.

    Article  PubMed  Google Scholar 

  190. Lloyd RV. Adrenal cortical tumors, pheochromocytomas and paragangliomas. Mod Pathol. 2011;24(Suppl 2):S58–65.

    Article  CAS  PubMed  Google Scholar 

  191. Cheah AL, Billings SD, Goldblum JR, Carver P, Tanas MZ, Rubin BP. STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics. Pathology. 2014;46(5):389–95.

    Article  CAS  PubMed  Google Scholar 

  192. Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014;27(3):390–5.

    Article  CAS  PubMed  Google Scholar 

  193. Han Y, Zhang Q, Yu X, Han X, Wang H, Xu Y, et al. Immunohistochemical detection of STAT6, CD34, CD99 and BCL-2 for diagnosing solitary fibrous tumors/hemangiopericytomas. Int J Clin Exp Pathol. 2015;8(10):13166–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  194. Thway K, Ng W, Noujaim J, Jones RL, Fisher C. The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol. 2016;24(4):281–92.

    Article  CAS  PubMed  Google Scholar 

  195. Vogels RJ, Vlenterie M, Versleijen-Jonkers YM, Ruijter E, Bekers EM, Verdijk MA, et al. Solitary fibrous tumor – clinicopathologic, immunohistochemical and molecular analysis of 28 cases. Diagn Pathol. 2014;9:224.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  196. Yoshida A, Tsuta K, Ohno M, Yoshida M, Narita Y, Kawai A, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol. 2014;38(4):552–9.

    Article  PubMed  Google Scholar 

  197. Lahlou G, Classe M, Wassef M, Just PA, Le Clerc N, Herman P, et al. Sinonasal inflammatory myofibroblastic tumor with anaplastic lymphoma kinase 1 rearrangement: case study and literature review. Head Neck Pathol. 2017;11(2):131–8.

    Article  PubMed  Google Scholar 

  198. Ong HS, Ji T, Zhang CP, Li J, Wang LZ, Li RR, et al. Head and neck inflammatory myofibroblastic tumor (IMT): evaluation of clinicopathologic and prognostic features. Oral Oncol. 2012;48(2):141–8.

    Article  CAS  PubMed  Google Scholar 

  199. Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol. 1998;15(2):85–101.

    CAS  PubMed  Google Scholar 

  200. Silva P, Bruce IA, Malik T, Homer J, Banerjee S. Nodular fasciitis of the head and neck. J Laryngol Otol. 2005;119(1):8–11.

    Article  CAS  PubMed  Google Scholar 

  201. Weinreb I, Shaw AJ, Perez-Ordonez B, Goldblum JR, Rubin BP. Nodular fasciitis of the head and neck region: a clinicopathologic description in a series of 30 cases. J Cutan Pathol. 2009;36(11):1168–73.

    Article  PubMed  Google Scholar 

  202. Cox DP, Daniels T, Jordan RC. Solitary fibrous tumor of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(1):79–84.

    Article  PubMed  Google Scholar 

  203. Smith SC, Gooding WE, Elkins M, Patel RM, Harms PW, McDaniel AS, et al. Solitary fibrous tumors of the head and neck: a multi-institutional clinicopathologic study. Am J Surg Pathol. 2017;41(12):1642–56.

    Article  PubMed  PubMed Central  Google Scholar 

  204. Kruse AL, Luebbers HT, Gratz KW, Obwegeser JA. Aggressive fibromatosis of the head and neck: a new classification based on a literature review over 40 years (1968–2008). Oral Maxillofac Surg. 2010;14(4):227–32.

    Article  PubMed  Google Scholar 

  205. Pena S, Brickman T, StHilaire H, Jeyakumar A. Aggressive fibromatosis of the head and neck in the pediatric population. Int J Pediatr Otorhinolaryngol. 2014;78(1):1–4.

    Article  PubMed  Google Scholar 

  206. Manes RP, Ryan MW, Batra PS, Mendelsohn D, Fang YV, Marple BF. Ossifying fibroma of the nose and paranasal sinuses. Int Forum Allergy Rhinol. 2013;3(2):161–8.

    Article  PubMed  Google Scholar 

  207. Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization classification of head and neck tumours: odontogenic and maxillofacial bone tumours. Virchows Arch. 2018;472(3):331–9.

    Article  PubMed  Google Scholar 

  208. Samadi DS, McLaughlin RB, Loevner LA, LiVolsi VA, Goldberg AN. Nuchal fibroma: a clinicopathological review. Ann Otol Rhinol Laryngol. 2000;109(1):52–5.

    Article  CAS  PubMed  Google Scholar 

  209. de Bree E, Karatzanis A, Hunt JL, Strojan P, Rinaldo A, Takes RP, et al. Lipomatous tumours of the head and neck: a spectrum of biological behaviour. Eur Arch Otorhinolaryngol. 2015;272(5):1061–77.

    Article  PubMed  Google Scholar 

  210. El-Monem MH, Gaafar AH, Magdy EA. Lipomas of the head and neck: presentation variability and diagnostic work-up. J Laryngol Otol. 2006;120(1):47–55.

    Article  PubMed  Google Scholar 

  211. Kim JS, Choi MS, Lee SJ, Park BC. Clinico-surgical characteristics of head and neck lipomas. Dermatol Surg. 2018;44(6):893–5.

    Article  CAS  PubMed  Google Scholar 

  212. Stewart MG, Schwartz MR, Alford BR. Atypical and malignant lipomatous lesions of the head and neck. Arch Otolaryngol Head Neck Surg. 1994;120(10):1151–5.

    Article  CAS  PubMed  Google Scholar 

  213. Gerry D, Fox NF, Spruill LS, Lentsch EJ. Liposarcoma of the head and neck: analysis of 318 cases with comparison to non-head and neck sites. Head Neck. 2014;36(3):393–400.

    Article  PubMed  Google Scholar 

  214. Davis EC, Ballo MT, Luna MA, Patel SR, Roberts DB, Nong X, et al. Liposarcoma of the head and neck: the University of Texas M. D. Anderson Cancer Center experience. Head Neck. 2009;31(1):28–36.

    Article  PubMed  Google Scholar 

  215. Rizer M, Singer AD, Edgar M, Jose J, Subhawong TK. The histological variants of liposarcoma: predictive MRI findings with prognostic implications, management, follow-up, and differential diagnosis. Skeletal Radiol. 2016;45(9):1193–204.

    Article  PubMed  Google Scholar 

  216. Zhu H, Sun J, Wei S, Wang D, Brandwein M. Well-differentiated laryngeal/hypopharyngeal liposarcoma in the MDM2 era report of three cases and literature review. Head Neck Pathol. 2017;11(2):146–51.

    Article  PubMed  Google Scholar 

  217. Billings SD, Folpe AL. Diagnostically challenging spindle cell lipomas: a report of 34 “low-fat” and “fat-free” variants. Am J Dermatopathol. 2007;29(5):437–42.

    Article  PubMed  Google Scholar 

  218. Dei Tos AP. Liposarcomas: diagnostic pitfalls and new insights. Histopathology. 2014;64(1):38–52.

    Article  PubMed  Google Scholar 

  219. Hogg ME, Wayne JD. Atypical lipomatous tumor/well-differentiated liposarcoma: what is it? Surg Oncol Clin N Am. 2012;21(2):333–40.

    Article  PubMed  Google Scholar 

  220. Mentzel T, Palmedo G, Kuhnen C. Well-differentiated spindle cell liposarcoma (‘atypical spindle cell lipomatous tumor’) does not belong to the spectrum of atypical lipomatous tumor but has a close relationship to spindle cell lipoma: clinicopathologic, immunohistochemical, and molecular analysis of six cases. Mod Pathol. 2010;23(5):729–36.

    Article  CAS  PubMed  Google Scholar 

  221. Nascimento AF, McMenamin ME, Fletcher CD. Liposarcomas/atypical lipomatous tumors of the oral cavity: a clinicopathologic study of 23 cases. Ann Diagn Pathol. 2002;6(2):83–93.

    Article  PubMed  Google Scholar 

  222. Ethunandan M, Mellor TK. Haemangiomas and vascular malformations of the maxillofacial region – a review. Br J Oral Maxillofac Surg. 2006;44(4):263–72.

    Article  CAS  PubMed  Google Scholar 

  223. Tucci FM, De Vincentiis GC, Sitzia E, Giuzio L, Trozzi M, Bottero S. Head and neck vascular anomalies in children. Int J Pediatr Otorhinolaryngol. 2009;73(Suppl 1):S71–6.

    Article  PubMed  Google Scholar 

  224. Giblin AV, Clover AJ, Athanassopoulos A, Budny PG. Pyogenic granuloma – the quest for optimum treatment: audit of treatment of 408 cases. J Plast Reconstr Aesthet Surg. 2007;60(9):1030–5.

    Article  CAS  PubMed  Google Scholar 

  225. Smith SC, Patel RM, Lucas DR, McHugh JB. Sinonasal lobular capillary hemangioma: a clinicopathologic study of 34 cases characterizing potential for local recurrence. Head Neck Pathol. 2013;7(2):129–34.

    Article  PubMed  Google Scholar 

  226. Albores-Saavedra J, Schwartz AM, Henson DE, Kostun L, Hart A, Angeles-Albores D, et al. Cutaneous angiosarcoma. Analysis of 434 cases from the surveillance, epidemiology, and end results program, 1973–2007. Ann Diagn Pathol. 2011;15(2):93–7.

    Article  PubMed  Google Scholar 

  227. Kohler HF, Neves RI, Brechtbuhl ER, Mattos Granja NV, Ikeda MK, Kowalski LP. Cutaneous angiosarcoma of the head and neck: report of 23 cases from a single institution. Otolaryngol Head Neck Surg. 2008;139(4):519–24.

    Article  PubMed  Google Scholar 

  228. Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP. Cutaneous angiosarcoma: a current update. J Clin Pathol. 2017;70(11):917–25.

    Article  CAS  PubMed  Google Scholar 

  229. Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013;137(2):289–94.

    Article  CAS  PubMed  Google Scholar 

  230. Patrikidou A, Vahtsevanos K, Charalambidou M, Valeri RM, Xirou P, Antoniades K. Non-AIDS Kaposi’s sarcoma in the head and neck area. Head Neck. 2009;31(2):260–8.

    Article  PubMed  Google Scholar 

  231. Ramirez-Amador V, Anaya-Saavedra G, Martinez-Mata G. Kaposi’s sarcoma of the head and neck: a review. Oral Oncol. 2010;46(3):135–45.

    Article  PubMed  Google Scholar 

  232. Nelson BL, Thompson LD. Sinonasal tract angiosarcoma: a clinicopathologic and immunophenotypic study of 10 cases with a review of the literature. Head Neck Pathol. 2007;1(1):1–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  233. Inwards CY. Update on cartilage forming tumors of the head and neck. Head Neck Pathol. 2007;1(1):67–74.

    Article  PubMed  PubMed Central  Google Scholar 

  234. Kato MG, Erkul E, Brewer KS, Harruff EE, Nguyen SA, Day TA. Clinical features of ectomesenchymal chondromyxoid tumors: a systematic review of the literature. Oral Oncol. 2017;67:192–7.

    Article  PubMed  Google Scholar 

  235. Aldojain A, Jaradat J, Summersgill K, Bilodeau EA. Ectomesenchymal chondromyxoid tumor: a series of seven cases and review of the literature. Head Neck Pathol. 2015;9(3):315–22.

    Article  PubMed  Google Scholar 

  236. Morris LG, Rihani J, Lebowitz RA, Wang BY. Chondromyxoid fibroma of sphenoid sinus with unusual calcifications: case report with literature review. Head Neck Pathol. 2009;3(2):169–73.

    Article  PubMed  PubMed Central  Google Scholar 

  237. Otto BA, Jacob A, Klein MJ, Welling DB. Chondromyxoid fibroma of the temporal bone: case report and review of the literature. Ann Otol Rhinol Laryngol. 2007;116(12):922–7.

    Article  PubMed  Google Scholar 

  238. Truschnegg A, Acham S, Kqiku L, Jakse N, Beham A. Ectomesenchymal chondromyxoid tumor: a comprehensive updated review of the literature and case report. Int J Oral Sci. 2018;10(1):4.

    Article  PubMed  PubMed Central  Google Scholar 

  239. Coca-Pelaz A, Rodrigo JP, Triantafyllou A, Hunt JL, Fernandez-Miranda JC, Strojan P, et al. Chondrosarcomas of the head and neck. Eur Arch Otorhinolaryngol. 2014;271(10):2601–9.

    PubMed  Google Scholar 

  240. Ellis MA, Gerry DR, Byrd JK. Head and neck chondrosarcomas: analysis of the surveillance, epidemiology, and end results database. Head Neck. 2016;38(9):1359–66.

    Article  PubMed  Google Scholar 

  241. Chapman DB, Lippert D, Geer CP, Edwards HD, Russell GB, Rees CJ, et al. Clinical, histopathologic, and radiographic indicators of malignancy in head and neck paragangliomas. Otolaryngol Head Neck Surg. 2010;143(4):531–7.

    Article  PubMed  Google Scholar 

  242. Mediouni A, Ammari S, Wassef M, Gimenez-Roqueplo AP, Laredo JD, Duet M, et al. Malignant head/neck paragangliomas. Comparative study. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131(3):159–66.

    Article  CAS  PubMed  Google Scholar 

  243. Williams MD. Paragangliomas of the head and neck: an overview from diagnosis to genetics. Head Neck Pathol. 2017;11(3):278–87.

    Article  PubMed  PubMed Central  Google Scholar 

  244. Jaber OI, Kirby PA. Alveolar soft part sarcoma. Arch Pathol Lab Med. 2015;139(11):1459–62.

    Article  CAS  PubMed  Google Scholar 

  245. Rekhi B, Ingle A, Agarwal M, Puri A, Laskar S, Jambhekar NA. Alveolar soft part sarcoma ‘revisited’: clinicopathological review of 47 cases from a tertiary cancer referral centre, including immunohistochemical expression of TFE3 in 22 cases and 21 other tumours. Pathology. 2012;44(1):11–7.

    Article  PubMed  Google Scholar 

  246. Kanhere HA, Pai PS, Neeli SI, Kantharia R, Saoji RR, D'Cruz AK. Alveolar soft part sarcoma of the head and neck. Int J Oral Maxillofac Surg. 2005;34(3):268–72.

    Article  CAS  PubMed  Google Scholar 

  247. Folpe AL, Deyrup AT. Alveolar soft-part sarcoma: a review and update. J Clin Pathol. 2006;59(11):1127–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  248. Kitsanou M, Andreopoulou E, Bai MK, Elisaf M, Drosos AA. Extensive lymphadenopathy as the first clinical manifestation in systemic lupus erythematosus. Lupus. 2000;9(2):140–3.

    Article  CAS  PubMed  Google Scholar 

  249. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343(26):1910–6.

    Article  CAS  PubMed  Google Scholar 

  250. Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia. 2007;21(12):2442–51.

    Article  CAS  PubMed  Google Scholar 

  251. Ciccone M, Agostinelli C, Rigolin GM, Piccaluga PP, Cavazzini F, Righi S, et al. Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays. Leukemia. 2012;26(3):499–508.

    Article  CAS  PubMed  Google Scholar 

  252. Gine E, Martinez A, Villamor N, Lopez-Guillermo A, Camos M, Martinez D, et al. Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica. 2010;95(9):1526–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  253. Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, et al. IgVH mutational status and clonality analysis of Richter’s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol. 2007;31(10):1605–14.

    Article  PubMed  Google Scholar 

  254. Timar B, Fulop Z, Csernus B, Angster C, Bognar A, Szepesi A, et al. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter’s syndrome. Leukemia. 2004;18(2):326–30.

    Article  CAS  PubMed  Google Scholar 

  255. Jaffe ES. Nasal and nasal-type T/NK cell lymphoma: a unique form of lymphoma associated with the Epstein-Barr virus. Histopathology. 1995;27(6):581–3.

    Article  CAS  PubMed  Google Scholar 

  256. Salaverria I, Philipp C, Oschlies I, Kohler CW, Kreuz M, Szczepanowski M, et al. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood. 2011;118(1):139–47.

    Article  CAS  PubMed  Google Scholar 

  257. Kuo TT. Kikuchi's disease (histiocytic necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy. Am J Surg Pathol. 1995;19(7):798–809.

    Article  CAS  PubMed  Google Scholar 

  258. Pileri S, Kikuchi M, Helbron D, Lennert K. Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol. 1982;395(3):257–71.

    Article  CAS  PubMed  Google Scholar 

  259. Braggio E, Dogan A, Keats JJ, Chng WJ, Huang G, Matthews JM, et al. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol. 2012;25(5):651–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  260. Cappabianca S, Colella G, Pezzullo MG, Russo A, Iaselli F, Brunese L, et al. Lipomatous lesions of the head and neck region: imaging findings in comparison with histological type. Radiol Med. 2008;113(5):758–70.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Duke University School of Medicine, Department of Pathology, Durham, NC, USA

    Chad M. McCall

  2. University of Texas Medical Branch, Department of Pathology, Galveston, TX, USA

    Adam L. Booth

  3. University of South Florida, Department of Pathology, Tampa, FL, USA

    Nicole D. Riddle

Authors
  1. Chad M. McCall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam L. Booth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicole D. Riddle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chad M. McCall .

Editor information

Editors and Affiliations

  1. Duke Health, Duke University Medical Center, Department of Pathology, Section of Head and Neck and Endocrine Pathology, Durham, NC, USA

    Danielle Elliott Range

  2. Duke Health, Duke University Medical Center, Department of Pathology, Section of Head and Neck and Endocrine Pathology, Durham, NC, USA

    Xiaoyin “Sara” Jiang

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

McCall, C.M., Booth, A.L., Riddle, N.D. (2019). Soft Tissue and Lymph Nodes of the Head and Neck. In: Elliott Range, D., “Sara” Jiang, X. (eds) Practical Head and Neck Pathology. Practical Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-10623-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-10623-2_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-10622-5

  • Online ISBN: 978-3-030-10623-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation